Results 181 to 190 of about 605,753 (293)

The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory Cirrhosis

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
While nucleos(t)ide analog (Nuc) therapy is the standard for chronic hepatitis B, pegylated interferon‐alpha (Peg‐IFN‐α) provides unique advantages, including finite treatment duration and long‐term benefits. However, its use in patients with compensated cirrhosis remains limited due to persistent safety concerns about potential decompensation and ...
Qiran Zhang   +32 more
wiley   +1 more source

Correction: Global Analysis of Protein and Small-Molecule Substrates of Ubiquitin-Like Proteins. [PDF]

open access: yesMol Cell Proteomics
Shao GC   +12 more
europepmc   +1 more source

Tracing change in the public perception of plants: insights from archives and social media in China

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
As urbanization accelerates, historic gardens serve as vital cultural treasures that offer spiritual and cultural support to the public. This study proposes an innovative approach that merges historical records from the Qing Dynasty with contemporary social media data to explore changes in public perceptions of these gardens.
Dong Xu   +4 more
wiley   +1 more source

Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma

open access: yesPrecision Medical Sciences, EarlyView.
The nanoparticle polymeric micellar paclitaxel plus nedaplatin regimen demonstrates superior efficacy and tolerable toxicities compared to the paclitaxel–nedaplatin combination as a first‐line treatment for advanced esophageal squamous cell carcinoma.
Yu‐Qing Cao   +7 more
wiley   +1 more source

Correction: Case Report: <i>FGFR1</i> mutation and massive chromosome loss drive malignant transformation of low-grade gliomas. [PDF]

open access: yesFront Oncol
Tang R   +11 more
europepmc   +1 more source

Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives

open access: yesPrecision Medical Sciences, EarlyView.
Graphical abstract represents the risk factors for lung cancer, TCM efficacy and clinical outcomes to future challenges. Abstract Lung cancer remains a leading cause of global cancer mortality. Despite advances in conventional treatments such as surgery, chemotherapy, targeted therapy, and immunotherapy, challenges including drug resistance, toxicity ...
Zhangdeng Chen, Liujun Bao
wiley   +1 more source

Home - About - Disclaimer - Privacy